Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in URGN — UroGen Pharma Ltd.

CIK 19617 NEW YORK, NY
Back to URGN Full portfolio

Position in URGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,455,217
+$1,075,446 QoQ
Shares Held
39,544
+87.2% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 190 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 54% Shared 0% None 46%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. URGN ranks #168 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in URGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,455,217 39,544
2026-03-31 $379,771 21,122
2025-12-31 $3,425,664 146,271
2025-09-30 $10,664,170 534,545
2025-06-30 $5,347,985 390,364
2025-03-31 $4,102,805 370,959
2024-12-31 $224,862 21,114
2024-09-30 $864,385 68,062
2024-06-30 $314,523 18,744
2024-03-31 $264,990 17,666
2023-12-31 $359,160 23,944
2023-09-30 $266,791 19,043
2023-06-30 $530,094 51,217
2023-03-31 $558,012 60,391
2022-12-31 $6,173 696
2022-09-30 $438,280 52,678
2022-06-30 $115,142 14,059
2022-03-31 $713,059 81,867
2021-12-31 $595,201 62,587
2021-09-30 $1,093,518 65,013
2021-06-30 $1,309,126 85,732
2021-03-31 $1,912,096 98,157
2020-12-31 $1,531,375 84,982
2020-09-30 $1,980,271 102,658
2020-06-30 $2,952,526 113,037
2020-03-31 $2,327,192 130,448